&bgr;-Myosin Heavy Chain Variant Val606Met Causes Very Mild Hypertrophic Cardiomyopathy in Mice, but Exacerbates HCM Phenotypes in Mice Carrying Other HCM Mutations

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation Research

• Publication date

  2014-05-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.115.303178PMID 24829265PMCID PMC4086907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy

  2013cited by this paper
• Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function

  2013cited by this paper
• Hypertrophic cardiomyopathy

  2013cited by this paper
• Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin Motor

  2012cited by this paper
• Population-Based Variation in Cardiomyopathy Genes

  2012cited by this paper
• Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history.

  2011cited by this paper
• Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

  2010cited by this paper
• Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy

  2010cited by this paper
• Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance.

  2009cited by this paper
• Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition

  2009influential reference
• Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy

  2008cited by this paper
• Functional Effects of the Hypertrophic Cardiomyopathy R403Q Mutation Are Different in an α- or β-Myosin Heavy Chain Backbone*

  2008cited by this paper
• Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.

  2007cited by this paper
• Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics

  2007cited by this paper
• Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function

  2006cited by this paper
• The genetic basis for cardiac remodeling.

  2005cited by this paper
• Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

  2005influential reference
• Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.

  2005cited by this paper
• R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level

  2004cited by this paper
• Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.

  2004cited by this paper
• Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

  2004influential reference
• Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.

  2004cited by this paper
• Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy

  2003cited by this paper
• Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban

  2003cited by this paper
• Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy

  2003cited by this paper
• What is known

  2003cited by this paper
• The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

  2002influential reference
• A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.

  2001cited by this paper
• Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

  2001cited by this paper
• The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age.

  2001cited by this paper
• An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy

  2000cited by this paper
• An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

  2000cited by this paper
• Homozygous Mutation in Cardiac Troponin T: Implications for Hypertrophic Cardiomyopathy

  2000cited by this paper
• Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.

  2000cited by this paper
• The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation

  1999cited by this paper
• Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

  1999cited by this paper
• Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

  1999cited by this paper
• Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy

  1999influential reference
• Genotype: phenotype correlations in hypertrophic cardiomyopathy.

  1998cited by this paper
• Sudden cardiac death in familial hypertrophic cardiomyopathy: Are “benign” mutations really benign?

  1997cited by this paper
• A Mouse Model of Familial Hypertrophic Cardiomyopathy

  1996cited by this paper
• Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.

  1995cited by this paper
• Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

  1995cited by this paper
• Hypertrophic cardiomyopathy.

  1994cited by this paper
• Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

  1994cited by this paper
• Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

  1994cited by this paper
• Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

  1992cited by this paper
• Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy Response by Ho on P 2450 Controversies in Cardiovascular Medicine

  year unknowncited by this paper

• Experimental Models of Hypertrophic Cardiomyopathy

  2025cites this paper
• Hypertrophic cardiomyopathy in identical twins: a case report with mismatch between genotype and phenotype

  2025cites this paper
• Novel double MYH7/MYBPC3 variants in a Chinese family of Hypertrophic Cardiomyopathy with Early-onset and Sudden Death.

  2025cites this paper
• Exploring MYH7 in Cardiomyopathies: Genetic Drivers and Clinical Outcomes

  2025cites this paper
• Explorando o MYH7 nas Cardiomiopatias: Fatores Genéticos e Desfechos Clínicos

  2025cites this paper
• Carrying both the heterozygous Myh6-R453C and Tnnt2-R92W mutations aggravate the hypertrophic cardiomyopathy phenotype in mice.

  2024cites this paper
• Long-term therapeutic efficacy and safety profiles of hpCas13d RNA editing in treating early-onset hypertrophic cardiomyopathy.

  2024cites this paper
• An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten

  2024cites this paper
• Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy

  2024cites this paper
• Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation

  2023cites this paper
• Slow myosin heavy chain 1 is required for slow myofibril and muscle fibre growth but not for myofibril initiation

  2023cites this paper
• MYH7 in cardiomyopathy and skeletal muscle myopathy

  2023cites this paper
• Diabetes disturbs functional adaptation of the remote myocardium after ischemia/reperfusion.

  2022cites this paper
• 4-Methylumbelliferone Attenuates Macrophage Invasion and Myocardial Remodeling in Pressure-Overloaded Mouse Hearts

  2021cites this paper
• CMR Characteristics, gene variants and long-term outcome in patients with left ventricular non-compaction cardiomyopathy

  2021cites this paper
• Genetic Testing in Patients with Hypertrophic Cardiomyopathy

  2021cites this paper
• Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imaging

  2021cites this paper
• Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy.

  2021cites this paper
• Identifying modifier genes for hypertrophic cardiomyopathy.

  2020cites this paper
• Circulation Research "In This Issue" Anthology.

  2020cites this paper
• (Complex approach towards patients with hypertrophic cardiomyopathy and indications to genetic testing)

  2020cites this paper
• Long-term outcomes and left ventricular diastolic function of sarcomere mutation-positive and mutation-negative patients with hypertrophic cardiomyopathy: a prospective cohort study.

  2020cites this paper
• Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury.

  2019cites this paper
• Circulation Research "In This Issue" Anthology.

  2019cites this paper
• Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.

  2019cites this paper
• Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype

  2019cites this paper
• Human Mutation

  2019cites this paper
• Genetic testing in patients with hypertrophic cardiomyopathy.

  2019cites this paper
• Mutant Muscle LIM Protein C58G causes cardiomyopathy through protein depletion

  2018cites this paper
• Impaired Ca2+ cycling of nonischemic myocytes contributes to sarcomere dysfunction early after myocardial infarction.

  2018cites this paper
• Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs

  2018cites this paper
• A contraction stress model of hypertrophic cardiomyopathy due to thick filament sarcomere mutations

  2018cites this paper
• A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations

  2018influential citation
• Novel Genetic Triggers and Genotype–Phenotype Correlations in Patients With Left Ventricular Noncompaction

  2017cites this paper
• Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development.

  2017cites this paper
• Modeling Genetic Susceptibility to Disease

  2017cites this paper
• Molecular Mechanism of Sarcomeric Cardiomyopathies

  2017cites this paper
• &agr;-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease

  2017cites this paper
• Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research

  2016cites this paper
• Mutations of NKX2.5 and GATA4 genes in the development of congenital heart disease.

  2016cites this paper
• Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

  2015cites this paper
• Hypertrophic cardiomyopathy: still connecting the dots between genotype and phenotype.

  2015cites this paper
• Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death: Genotype-Phenotype Intersection.

  2015cites this paper
• Genetic advances in sarcomeric cardiomyopathies: state of the art

  2015cites this paper
• Two strikes and you're out: gene-gene mutation interactions in HCM.

  2014cites this paper